The subject of this order is the successive delivery of medicines for the Oncology Center - the Institute Maria Skłodowska-Curie Branch in Gliwice, hereinafter referred to as the Employer.
A detailed description of the subject of the contract is included in the assortment and price specification as an attachment
No. 2.1 - 2.9 to the ToR and the model contract constituting Annex 4 to the ToR.
If the medicine in the international name is on the reimbursement list, then the medicine offered must be on it and its price must be equal to or lower than the funding limits.
The contracting authority does not anticipate concluding a framework agreement, establishing a dynamic purchasing system, electronic auction or supplementary orders.
Detailed information on these proceedings is contained in the ToR.
Task No. 1 - Arsenic trioxide
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.1 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 2 - Blinatumomab
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.2 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 3 - Celecoxib
A detailed description of the subject of the contract is included in the assortment and price specification constituting Annex 2.3 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 4 - Cytarabine
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.4 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 5 - Fludarabine 2
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.5 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task No. 6 - Tissue adhesive
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.6 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task No. 7 - Mitomycin
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.7 to the ToR and the model contract constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task No. 8 - Recipe
A detailed description of the subject of the contract is included in the product and price specification constituting Annex 2.8 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with an expiry date shorter than 12 months only if the Contractor obtains the written consent of the Employer.
Task No. 9 - Miscellaneous
A detailed description of the subject of the contract is included in the assortment and price specification constituting Annex 2.9 to the ToR and the contract template constituting Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product that is traded in Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with
With the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. Purchaser - not applicable to target import.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with an expiry date shorter than 12 months only if the Contractor obtains the written consent of the Employer.